Now showing items 1-1 of 1

    • The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL 

      Wissenschaftlicher Artikel
      Flinn, Ian W.; Hillmen, Peter; Montillo, Marco; Nagy, Zsolt; Illes, Arpad; Etienne, Gabriel; Delgado, Julio; Kuss, Bryone J.; Tam, Constantine S.; Gasztonyi, Zoltan; Offner, Fritz; Lunin, Scott; Bosch, Francesco; Davids, Matthew S.; Lamanna, Nicole; Jaeger, Ulrich; Ghia, Paolo; Cymbalista, Florence; Portell, Craig A.; Skarbnik, Alan P.; et al. (Universität Ulm, 2018)